1. Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine;Ansaldi;Clin. Vaccine Immunol.,2011
2. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr. Infect. Dis. J.,2000
3. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998–2003;Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly Rep.,2005
4. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine — United States, 2007;Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly Rep.,2010
5. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children — Advisory Committee on Immunization Practices (ACIP), 2010;Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly Rep.,2010